Analysed BIOCARDIA INC (BCDA:NASDAQ) News Sources
FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF
05-06-2026
yahoo.com
BioCardia Shares Rally After FDA Supports Regulatory Path for Heart Failure Therapy (BCDA)
05-06-2026
advfn.com
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
18-06-2026
yahoo.com
What is the current price of BIOCARDIA INC (BCDA:NASDAQ)?
The current price of BIOCARDIA INC (BCDA:NASDAQ) is $0.7758.
BIOCARDIA INC (BCDA:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOCARDIA INC (BCDA:NASDAQ) since the previous trading day is $-0.0325.
BIOCARDIA INC (BCDA:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOCARDIA INC (BCDA:NASDAQ) since the previous trading day is -4.0208%.
What is the most recent average sentiment score for BIOCARDIA INC (BCDA:NASDAQ)?
The most recent average sentiment score for BIOCARDIA INC (BCDA:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for BIOCARDIA INC (BCDA:NASDAQ)?
The most recent sentiment for BIOCARDIA INC (BCDA:NASDAQ) is .
SEC-8K** Filing Available For BIOCARDIA INC (BCDA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.